Patent ID: 8440657

Claim:
A method of treatment of arterial thromboembolic disorders in humans and animals comprising administering to the human or animal an therapeutically effective amount of a compound of formula (I): in which R 1 is trifluoromethyl, 1,1-difluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, difluoromethoxy, trifluoromethoxy or ethyl, R 2 is 2-hydroxyeth-1-yl, 2-methoxyeth-1-yl, 2-ethoxyeth-1-yl, cyclopropyl or 1-methoxycycloprop-1-yl, R 3 is a group of the formula where * is the point of attachment to the carbonyl group, or a salt thereof.